Đang chuẩn bị liên kết để tải về tài liệu:
Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Raltegravir (Isentress®)(RALT) has demonstrated excellent efficacy in both treatment-experienced and naïve patients with HIV-1 infection, and is the first strand transfer integrase inhibitor to be approved for use in HIV infected adults worldwide. | Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells